Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2006Clinical Transplantation

Two‐dose basiliximab compared with two‐dose daclizumab in renal transplantation: a clinical study

View Full Paper
Ask AI
Bookmark
Share

Authors

MLMinzhuan LinThird Affiliated Hospital of Guangzhou Medical UniversityMAMing AiminMZMing ZhaoChina General Nuclear Power Corporation (China)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lin et al. (2006) studied this question.

synapsesocial.com/papers/6a71fbcf35aa2c282ce3083dhttps://doi.org/10.1111/j.1399-0012.2005.00488.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Early experience with two‐dose daclizumab in the prevention of acute rejection in cardiac transplantation2004 · 12 citations
  2. 2Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation12003 · 298 citations
  3. 3The Banff 97 working classification of renal allograft pathology1999 · 3,059 citations
  4. 4Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials2003 · 140 citations
  5. 5DETERMINANTS OF GRAFT SURVIVAL AFTER RENAL TRANSPLANTATION11996 · 170 citations